Science Explorer Back to mapMap
Discussion
Company · Yokohama · Japan

Prism Biolab Corporation (Japan)

prismbiolab.comROR OpenAlex
Research works
5
▼ 20% vs 2018-21
Citations
77
15.1 per fractional work
Top-10% rate
1.5%
all institutions 10.0%
Open access
79%
world 40%
International
34%
world 18%
Prism Biolab Corporation (Japan)

Not ranked overall: Prism Biolab Corporation (Japan) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Prism Biolab Corporation (Japan) work in?

In all years, 53% of research at Prism Biolab Corporation (Japan) is in Life Sciences, 41% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (41%), Medicine (41%), Neuroscience (7%). It does 1.5× the world's share of Life Sciences.

Life Sciences: 3 fractional works · 53.5% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 40.8% of its workMolecular Biology: 2 fractional works · 37.5% of its workCancer Research: 0 fractional works · 2.2% of its workGenetics: 0 fractional works · 0.8% of its workBiotechnology: 0 fractional works · 0.2% of its workCell Biology: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 6.7% of its workNeurology: 0 fractional works · 1.6% of its workBehavioral Neuroscience: 0 fractional works · 1.4% of its workBiological Psychiatry: 0 fractional works · 1.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.0% of its workCognitive Neuroscience: 0 fractional works · 0.8% of its workDevelopmental Neuroscience: 0 fractional works · 0.8% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 4.3% of its workToxicology: 0 fractional works · 4.3% of its workAgricultural and Biological Sciences: 0 fractional works · 1.6% of its workAgronomy and Crop Science: 0 fractional works · 1.6% of its workHealth Sciences: 2 fractional works · 40.6% of its workMedicine: 2 fractional works · 40.6% of its workPharmacology: 0 fractional works · 9.9% of its workOncology: 0 fractional works · 8.3% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 6.5% of its workPulmonary and Respiratory Medicine: 0 fractional works · 4.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 3.4% of its workSurgery: 0 fractional works · 3.4% of its workPhysiology: 0 fractional works · 2.2% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.4% of its workHematology: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.2% of its workPhysical Sciences: 0 fractional works · 5.9% of its workChemistry: 0 fractional works · 4.3% of its workOrganic Chemistry: 0 fractional works · 4.3% of its workEngineering: 0 fractional works · 1.6% of its workBuilding and Construction: 0 fractional works · 1.6% of its workALL ITS WORKPrism BiolabCorporation…5fractional works, all years
Life Sciences53%Physical Sciences6%Health Sciences41%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 7 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology240.8%
    2. Neuroscience06.7%
    3. Pharmacology, Toxicology and Pharmaceutics04.3%
    4. Agricultural and Biological Sciences01.6%
    1. Medicine240.6%
    1. Chemistry04.3%
    2. Engineering01.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Prism Biolab Corporation (Japan)?

The most cited paper from Prism Biolab Corporation (Japan) is "E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling" (Kazuhiko Yamada et al., 2021), with 65 citations. Next come "Phylogenetic analysis of methyl coenzyme-M reductase detected from the bovine rumen" (49) and "Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma" (43).

Most cited papers
#PaperReleasedCitations
1 E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling Kazuhiko Yamada et al. · Cancer Research 6 Jan 2021 65
2 Phylogenetic analysis of methyl coenzyme-M reductase detected from the bovine rumen Noriko TATSUOKA, N. Mohammed, Makoto Mitsumori et al. · Letters in Applied Microbiology 30 Jul 2004 49
3 Anti-tumor Activity of the Small Molecule Inhibitor PRI-724 Against β-Catenin-activated Hepatocellular Carcinoma Ryosuke Gabata, Kenichi Harada, Yuki H. Mizutani et al. · Anticancer Research Open access Sep 2020 43
4 The novel inhibitor PRI-724 for Wnt/β-catenin/CBP signaling ameliorates bleomycin-induced pulmonary fibrosis in mice Hiroyasu Okazaki, Seidai Sato, Kazuya Koyama et al. · Experimental Lung Research Open access 12 Jul 2019 40
5 A mimetic of the mSin3-binding helix of NRSF/REST ameliorates abnormal pain behavior in chronic pain models Hiroshi Ueda, Jun-ichi Kurita, Hiroyuki Neyama et al. · Bioorganic & Medicinal Chemistry Letters 7 Sep 2017 28
All 16 most cited papers, with filters and sorting

Which research topics does Prism Biolab Corporation (Japan) publish most on?

By volume in 2022-now: vaccines and immunoinformatics approaches, Peptidase Inhibition and Analysis, Monoclonal and Polyclonal Antibodies Research and Nicotinic Acetylcholine Receptors Study.

vaccines and immunoinfor…0vaccines and immunoinformatics approaches: 0 fractional worksPeptidase Inhibition and…0Peptidase Inhibition and Analysis: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksNicotinic Acetylcholine Receptors Study: 0 fractional worksCardiac electrophysiology and arrhythmias: 0 fractional worksIon channel regulation a…0Ion channel regulation and function: 0 fractional works
Molecular BiologyOncologyRadiology, Nuclear Medicine and ImagingCardiology and Cardiovascular Medicine

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 vaccines and immunoinformatics approaches Molecular Biology 0 works
  2. 2 Peptidase Inhibition and Analysis Oncology 0 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Nicotinic Acetylcholine Receptors Study Molecular Biology 0 works
  5. 5 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 0 works
  6. 6 Ion channel regulation and function Molecular Biology 0 works
  7. 7 Kruppel-like factors research Molecular Biology 0 works
  8. 8 Cancer-related gene regulation Molecular Biology 0 works
  9. 9 Chronic Myeloid Leukemia Treatments Hematology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available78.7%not open21.3%

World: 40% of research is openly available.

with international co-authors34.5%domestic only65.5%

World: 18% is written across borders.

How has Prism Biolab Corporation (Japan)'s research output changed?

Output in 2022-2025 was 20% lower than in 2018-2021.

2005201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Prism Biolab Corporation (Japan) as a percentage of every work published that year, 0.000021% in 2022.

0.000010%0.000020%0.000030%Prism Biolab Corporation (Japan)0.0000036% in 202420102020

Fractional works of Prism Biolab Corporation (Japan) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Yokohama

All research institutions in Yokohama

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Prism Biolab Corporation (Japan). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.